RF (radiofrequency) ablation and among latest NICE (UK National Institute for Clinical Excellence) approvals:
This article was originally published in Clinica
Executive Summary
The National Institute for Clinical Excellence (NICE) has published its verdict on the safety and efficacy of five new interventional procedures. Three of these were deemed to have sufficient evidence to support their use in the National Health Service. These are coblation tonsillectomy, percutaneous vertebroplasty and radiofrequency ablation of varicose veins. The uncertainty surrounding the other two - stent-graft placement in abdominal aortic aneurysms and stereotactic radiosurgery for trigeminal neuralgia using a gamma knife - means that clinicians wishing to provide these will need to perform them under the strictest approval, consent, and clinical audit conditions.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.